drugset / Trial / NCT01066702

Confirmatory Study of NeoCart in Knee Cartilage Repair

NCT01066702 ↗

Phase 3 Terminated 245 enrolled Histogenics Corporation
RandomizedParallel-groupOpen-labelTreatment

Summary

This confirmatory study is a prospective randomized trial comparing the efficacy and safety of an autologous chondrocyte tissue implant (NeoCart) to the surgical intervention microfracture in the treatment of cartilage defects in the knee.

Timeline

Start
2010-05
Primary completion
2019-03
Completion
2019-03

Outcome

Outcome not reported

Stopped: “company dissolution”

Drugs

EvaluationDrugModalityDoseRoute
Subject NeoCart Cell therapy — —